Forbes contributors publish independent expert analyses and insights. I write about investing, markets and Berkshire Hathaway. Berkshire Hathaway’s (BRK/A, BRK/B) Warren Buffett and his late partner ...
Johnson & Johnson is up ~45% in 2025, with robust execution and financials, but current valuations limit further upside. JNJ's organic growth and margin expansion remain moderate, with recent gains ...
Building an investment portfolio is a personal experience: What suits one investor may be ill-fitting for another. Factors such as risk tolerance and time horizon influence how an investor constructs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results